Leylah Drusbosky
0000-0002-9401-4600
Publication & Citation Trends
Publications
0 total
Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approach
Cited by 0
Semantic Scholar
CTIM-23. FIRST-IN-HUMAN IMMUNOTHERAPY TARGETING LYMPHOPENIA IN RECURRENT GLIOBLASTOMA MULTIFORM (GBM): NAI AND PD-L1 T-HANK PLUS BEVACIZUMAB WITH COMPLETE RESPONSE
Cited by 1
Semantic Scholar
A Proposed Statistical Approach for Conducting a Longitudinal Assessment of Circulating Tumor DNA
Cited by 0
Semantic Scholar
Singe agent off-the-shelf CAR-NK (CD-19 t-haNK) cell therapy in combination with rituxumab Results in complete response in participants with waldenstrom's macroglobulinemia
Cited by 0
Semantic Scholar
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131).
Cited by 1
Semantic Scholar
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte–Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin–Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer
Cited by 3
Semantic Scholar
Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) OA
Cited by 7
Semantic Scholar
Abstract 969: Tumor-agnostic ctDNA monitoring in patients with metastatic HR+/HER2- breast cancer receiving first-line CDK4/6 inhibitor and endocrine therapy
Cited by 0
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(117)
Lung Cancer Treatments and Mutations
(102)
Colorectal Cancer Treatments and Studies
(87)
Genetic factors in colorectal cancer
(57)
Acute Myeloid Leukemia Research
(37)
Affiliations
Jacksonville College
WinnMed
University of Florida
Guardant (United States)
ImmunityBio (United States)